A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host disease.
Herrera AF, Kim HT, Bindra B, Jones KT, Alyea EP 3rd, Armand P, Cutler CS, Ho VT, Nikiforow S, Blazar BR, Ritz J, Antin JH, Soiffer RJ, Koreth J.
Herrera AF, et al. Among authors: cutler cs.
Biol Blood Marrow Transplant. 2014 Nov;20(11):1737-43. doi: 10.1016/j.bbmt.2014.06.040. Epub 2014 Jul 10.
Biol Blood Marrow Transplant. 2014.
PMID: 25017765
Free PMC article.
Clinical Trial.